These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23480753)

  • 1. High expression of ABCC1 indicates poor prognosis in intrahepatic cholangiocarcinoma.
    Srimunta U; Sawanyawisuth K; Kraiklang R; Pairojkul C; Puapairoj A; Titipungul T; Hahnvajanawong C; Tassaneeyakul W; Wongkham C; Wongkham S; Vaeteewoottacharn K
    Asian Pac J Cancer Prev; 2012; 13 Suppl():125-30. PubMed ID: 23480753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of ABCG2 in moderately and poorly differentiated intrahepatic cholangiocarcinoma.
    Larbcharoensub N; Sornmayura P; Sirachainan E; Wilasrusmee C; Wanmoung H; Janvilisri T
    Histopathology; 2011 Aug; 59(2):235-46. PubMed ID: 21884202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine triphosphate-binding cassette subfamily C members in liver hepatocellular carcinoma: Bioinformatics-driven prognostic value.
    Meng X; Dong S; Yangyang L; Wang S; Xu X; Liu T; Zhuang X
    Medicine (Baltimore); 2022 Feb; 101(7):e28869. PubMed ID: 35363194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of ATP-binding cassette transporter genes in nasopharyngeal carcinoma].
    DU SS; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):449-52. PubMed ID: 18359711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs.
    Borel F; Han R; Visser A; Petry H; van Deventer SJ; Jansen PL; Konstantinova P;
    Hepatology; 2012 Mar; 55(3):821-32. PubMed ID: 21932399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.
    Bergeat D; Fautrel A; Turlin B; Merdrignac A; Rayar M; Boudjema K; Coulouarn C; Sulpice L
    J Surg Res; 2016 Jun; 203(2):441-50. PubMed ID: 27363654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
    Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
    Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
    Spitzwieser M; Pirker C; Koblmüller B; Pfeiler G; Hacker S; Berger W; Heffeter P; Cichna-Markl M
    Oncotarget; 2016 Nov; 7(45):73347-73369. PubMed ID: 27689338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma.
    Jin GZ; Dong W; Dong H; Yu H; Chen J; Yu WL; Li AJ; Cong WM; Wu MC
    Oncotarget; 2015 Nov; 6(36):39357-64. PubMed ID: 26472105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance and molecular mechanisms of adenosine triphosphate-binding cassette subfamily C members in gastric cancer.
    Mao X; He Z; Zhou F; Huang Y; Zhu G
    Medicine (Baltimore); 2019 Dec; 98(50):e18347. PubMed ID: 31852133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
    Albermann N; Schmitz-Winnenthal FH; Z'graggen K; Volk C; Hoffmann MM; Haefeli WE; Weiss J
    Biochem Pharmacol; 2005 Sep; 70(6):949-58. PubMed ID: 16054595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival.
    Yamada A; Ishikawa T; Ota I; Kimura M; Shimizu D; Tanabe M; Chishima T; Sasaki T; Ichikawa Y; Morita S; Yoshiura K; Takabe K; Endo I
    Breast Cancer Res Treat; 2013 Feb; 137(3):773-82. PubMed ID: 23288347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of ATP binding cassette transporters is associated with poor prognosis in acute myeloid leukemia.
    Liu B; Li LJ; Gong X; Zhang W; Zhang H; Zhao L
    Oncol Lett; 2018 May; 15(5):6671-6677. PubMed ID: 29616130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
    Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
    Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
    Terashita K; Chuma M; Hatanaka Y; Hatanaka K; Mitsuhashi T; Yokoo H; Ohmura T; Ishizu H; Muraoka S; Nagasaka A; Tsuji T; Yamamoto Y; Kurauchi N; Shimoyama N; Toyoda H; Kumada T; Kaneoka Y; Maeda A; Ogawa K; Natsuizaka M; Kamachi H; Kakisaka T; Kamiyama T; Taketomi A; Matsuno Y; Sakamoto N
    J Clin Pathol; 2016 Jul; 69(7):593-9. PubMed ID: 26670746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
    Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
    Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
    Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
    Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
    Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.